Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.

Ghoreschi, Kamran; Balato, Anna; Enerbäck, Charlotta; Sabat, Robert

Ghoreschi, Kamran; Balato, Anna; Enerbäck, Charlotta; Sabat, Robert.

Afiliación

Ghoreschi K; Department of Dermatology, Venereology, and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: kamran.ghoreschi@charite.de.
Balato A; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Enerbäck C; Ingrid Asp Psoriasis Research Center, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Sabat R; Psoriasis Research and Treatment Centre, Charité-Universitätsmedizin Berlin, Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany.

Lancet ; 397(10275): 754-766, 2021 02 20.

Article en En | MEDLINE | ID: mdl-33515492

Asunto(s)

Interleucina-17/metabolismo; Interleucina-23/metabolismo; Queratinocitos/metabolismo; Psoriasis/tratamiento farmacológico; Psoriasis/metabolismo; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psoriasis / Queratinocitos / Interleucina-17 / Interleucina-23 Límite: Humans Idioma: En Revista: Lancet Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google